http://eclipsebreasthealth.com
Eclipse Breast Health Technologies has launched a crowdfunding campaign to test and eventually bring to market a wireless sensor meant to aid in the early detection of breast cancer and the tracking of patients being treated for the disease. The campaign is meant to support the company as it goes through the FDA approval process. With the simplicity of the home self-check, and the potential vast amount of data that the company can gather on its servers, this is a potentially disruptive clinical tool. Clearly those cases where the device did not detect cancer when it should have will make or break this product.
The system consists of a handheld imaging device paired with imaging software that tracks changes in breast density over time, and also incorporates an element of social networking. Eclipse says the device, which uses what the company calls “transphotonic” technology – combining low-energy photons and light sensors, without the need for radiation – is as much as five times as sensitive as the human hand.
The imaging device links wirelessly or by USB to a PC, smartphone or tablet, where a Web application creates a visual representation of the self-exam and helps quantify observations. Data is uploaded to patient accounts on a platform that calls Pink Cloud. From there, women can compare readings over time, share the information with their physicians or connect with others on Pink Cloud, which incorporates a social network of Eclipse users.
Leave a Reply